Arzeda logo

Arzeda

arzeda.com

Arzeda designs novel proteins and enzymes using AI-driven computational methods, delivering BioSolutions for industries such as food and nutrition, home and personal care, advanced materials, and pharmaceuticals. Its products aim to improve customer products and manufacturing processes while reducing environmental impact.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
79
Registered name
Arzeda Corp Seattle business license
Members see funding amounts.
.
Founders
Alexandre Zanghellini, David Baker

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Arzeda

See all 9

TerraPower Isotopes’ Chris Dunckley Leads Team Extracting Ultra-Rare Actinium-225 from Cold War Waste for Cancer Therapy

Chris Dunckley, director of chemistry and engineering at TerraPower Isotopes, leads a multidisciplinary team extracting the ultra-rare radioisotope actinium-225 from Cold War nuclear waste to develop promising cancer therapies. His leadership and scientific expertise help transform radioactive weapons waste into potentially life-saving medical treatments.

Seattle Startup Arzeda Raises $38M to Advance Protein Design for Industrial and Agricultural Applications

Seattle-based protein design startup Arzeda raised $38 million in its latest funding round, bringing total investments to $86 million to develop enzymes for industrial and agricultural uses. The company works with major partners like Unilever, BP, and Gore-Tex makers, and was the first spinout from the University of Washington's Institute for Protein Design.

By Arzeda

See all 35

Arzeda tells National Security Commission U.S. biotech lacks domestic manufacturing, risking commercial scale‑up to overseas partners

Arzeda, a Seattle enzyme-design startup that reaches about 1.8 billion consumers, says U.S. biotech companies have strong science but lack domestic manufacturing capacity and workforce, forcing them to rely on Western Europe and India; the National Security Commission on Emerging Biotechnology visited to hear calls for investment and infrastructure to keep production stateside.

Arzeda and KENT Specialty Milling Forge Product Development Agreement to Combine AI Protein Design with Manufacturing Scale

Arzeda and KENT Specialty Milling have entered a product development agreement to combine Arzeda’s AI-driven Intelligent Protein Design Technology with KENT’s manufacturing scale and market expertise to develop customer-focused protein solutions. The partnership aims to design and validate novel proteins to improve performance and efficiency across relevant end markets, though technical details and milestones remain undisclosed.

People

See all 5
  • Alex Zanghelini Co-founder
  • Alexandre Zanghellini
    Alexandre Zanghellini Executive Officer, Director, Promoter, Co-founder and PhD — Co-Founder & Chief Executive Officer
  • Ken Barrett Executive, MBA, MS — Chief Business Officer

Online

Questions about Arzeda

What is Arzeda?

Arzeda is a startup based in Seattle, WA, US that uses AI-driven computational methods to design proteins and enzymes. It delivers BioSolutions for food and nutrition, home and personal care, advanced materials, and pharmaceuticals.

What has Arzeda been in the news for?

GeekWire reported in September 2024 on Arzeda’s work to advance protein design for industrial and agricultural applications.

Who are the people behind Arzeda?

Alexandre Zanghellini is Arzeda’s co-founder and chief executive officer, and Alex Zanghelini is listed as a co-founder. Ken Barrett is chief business officer, and Sanjay Pal is chief financial officer.

Who invested in Arzeda, and how much has it raised?

Members of Seattle Flow see Arzeda's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Arzeda based?

Arzeda is based in Seattle, WA, US.

When was Arzeda founded?

Arzeda was founded in 2009.